about
Associations Between Hyperuricemia and Chronic Kidney Disease: A ReviewFunctional and Structural Characterization of Purine Nucleoside Phosphorylase from Kluyveromyces lactis and Its Potential Applications in Reducing Purine Content in FoodNew and improved strategies for the treatment of goutUric acid as a target of therapy in CKD.Renal co-morbidity in patients with rheumatic diseases.The 3-Year Incidence of Gout in Elderly Patients with CKD.Evaluation of the Effectiveness of Xanthine Oxidoreductase Inhibitors on Haemodialysis Patients using a Marginal Structural Model.
P2860
Q26796333-BA3D2019-3247-4BE4-97E6-6D9DB7446AB7Q28552877-D28F5D8E-ED11-484B-A090-79F761FC372BQ35026692-4960CF67-A3BB-43E8-B89A-BD2CEBCD994CQ36476464-013B695E-2DE2-4401-AA48-C8F75DEF58F1Q37896728-9B0FF90E-759B-4CE1-A626-BF2E1A4F29E6Q40353089-C953A884-D9B1-47C6-9ABD-D4EE467D2467Q42630143-6D16028E-A6E4-478E-A7DE-CE060E24E8CA
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Management of hyperuricemia and gout in CKD.
@en
Management of hyperuricemia and gout in CKD.
@nl
type
label
Management of hyperuricemia and gout in CKD.
@en
Management of hyperuricemia and gout in CKD.
@nl
prefLabel
Management of hyperuricemia and gout in CKD.
@en
Management of hyperuricemia and gout in CKD.
@nl
P1476
Management of hyperuricemia and gout in CKD.
@en
P2093
Angelo L Gaffo
Kenneth G Saag
P304
P356
10.1053/J.AJKD.2008.07.035
P577
2008-11-01T00:00:00Z